Evaluation of surgery for acromegaly: Role of intraoperative growth hormone measurement?

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 6, 2001, Pages 459-470

  Valdemarsson, S ^a   Ljunggren, S ^a   Cervin, A ^a   Svensson, C ^a   Isaksson, A ^a   Nordstrom C H ^a   Siesjo P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acromegaly; Growth hormone; Pituitary disease; Pituitary function; Pituitary surgery

Indexed keywords

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; GROWTH HORMONE RELEASE; HALF LIFE TIME; HEMOCONCENTRATION; HORMONE DETERMINATION; HUMAN; HYPOPHYSECTOMY; INTRAOPERATIVE PERIOD; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIABILITY; SURGICAL RISK; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADULT; AGED; FEMALE; GROWTH HORMONE; HALF-LIFE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PITUITARY GLAND; PITUITARY NEOPLASMS; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, OPERATIVE;

EID: 0034812806     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510152567103     Document Type: Article

References (17)

1. Current treatment guidelines for acromegaly
2. Does treatment of acromegaly affect life expectancy?
3. Mortality and cancer incidence in acromegaly: A retrospective cohort study
4. Transsphenoidal microsurgery for growth hormone secreting pituitary adenomas: Initial outcome and long-term results
5. Long-term mortality and transsphenoidal surgery and adjunctive therapy for acromegaly
6. Increased cerebrovascular mortality in patients with hypopituitarism
7. Premature mortality due to cardiovascular disease in hypopituitarism
8. Early postoperative growth hormone levels: High predictive value for long-term outcome after surgery for acromegaly
9. Intraoperative GH measurements in acromegaly
10. Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery
11. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly
12. Can intraoperative GH measurements in acromegalic subjects predict completeness of surgery?
13. A decade of pituitary microsurgery
14. Early postoperative growth hormone levels predict the result of transsfenoidal tumour removal in acromegaly
15. Long-term endocrinological Follow-up in 115 patients who underwent transsphenoidal surgery for acromegaly
16. Assessment of growth hormone (GH) plasma clearance rate, half-life and volume distribution in acromegalic patients: The combined GH-octreotide infusion
17. Growth hormone secretion in recently operated acromegalic patients